Cannabis: Psychosis and Schizophrenia

Main Point 1 – 2:56
*Subpoint 1A – Intro) – 4:25
1. Neuropsychopharmacology 2004 – http://ift.tt/1ZG8dqT
2. Biological Psychiatry 2005 – http://ift.tt/1mq85hf
3. Psychological Medicine 2013 – http://ift.tt/1ZG8dqW
4. Journal of Forensic Legal Medicine 2012 – http://ift.tt/1mq87Wn
—Minipoint 1A.1–
1. Neuropsychopharmacology 2009
http://ift.tt/1ZG8fz1
—Minipoint 1A.2–
1. Biological Psychiatry 2013 – http://ift.tt/1mq87Wr
2. European Archives of Psychiatry and Clinical Neuroscience 2010 – http://ift.tt/1ZG8dqY
3. Psychopharmacology 2012 – http://ift.tt/1mq87Wv
—Minipoint 1A.3–
1. Journal of the American Academy of Child and Adolescent Psychiatry 2012 – http://ift.tt/1ZG8fz6
2. Psychological Medicine 2011 – http://ift.tt/1mq85hj –
—Minipoint 1A.4—
1. Neuropsychopharmacology 2011 – http://ift.tt/1ZG8dr6
2. Cell Journal 2012 – http://ift.tt/1R6obJM
3. Neuroscience Journal 2011 – http://ift.tt/1PD2JZk ,
http://ift.tt/1R6obJP
4. Brain: A Journal of Neurology 2012 – http://ift.tt/1PD2Lk3
5. Progress in Neuropsychopharmacology and Biological Psychiatry 2007 – http://ift.tt/1R6obJQ
—Minipoint 1A.5—
1. European Journal of Neuropsychopharmacology 2008 – http://ift.tt/1PD2JZm
2. Neuropsychopharmacology 2012 – http://ift.tt/1R6obJS

*Subpoint 1B) 13:58
1. The British Journal of Psychiatry 2005 – http://ift.tt/1ZG8dHq , http://ift.tt/1mq87WC
2. L’Encephale 2009 – http://ift.tt/1ZG8dHt –
3. Canadian Journal of Psychiatry 2006 – http://ift.tt/1mq85hq
4. British Medical Journal 2005 – http://ift.tt/1PD2Lk5
5. British Journal of Psychiatry 2010 – http://ift.tt/1PD2JZq –
6. “Epidemiological and Biological Mechanisms of Cannabis as a Cause of Psychosis” 2012, page 102 – http://ift.tt/1R6obJX
7. Archives of General Psychiatry 2010 – http://ift.tt/1PD2JZs
8. Current Pharmaceutical Design 2012 — http://ift.tt/1R6o9Bz
9. Archives of General Psychiatry 2011 – http://ift.tt/1PD2LAk
10. Lancet 2007 – http://ift.tt/1FSquHq
11. British Medical Journal 2011 – http://ift.tt/1R6o9BB
12. Psychological Medicine 2012 – http://ift.tt/1PD2JZw

*Subpoint 1C) 19:10
1. Schizophrenia Bulletin 2012 – http://ift.tt/1R6o9BC
2. Progress in Neuropsychopharmacology and Biological Psychiatry 2007 http://ift.tt/1mq87WA
3. Schizophrenia Research 2011 – http://ift.tt/1PD2KfK
4. Praxis 2011 – http://ift.tt/1R6oc0d
5. Drug and Alcohol Dependence 2011 – http://ift.tt/1ZG8dHx
6. Biological Psychiatry 2005 – http://ift.tt/1mq85hf

Main point 2: The counter attack! 25:40
Subpoint 2a – Intro) 28:12
—Minipoint 2A.1—Dopamine
1. Psychopharmacology 2012 – http://ift.tt/1R6o9BF –
2. Drug and Alcohol Dependence 2013 – http://ift.tt/1PD2LAo –
3. Neuroimage 2009 – http://ift.tt/1mq88d5 —
4. Psychopharmacology 2011 – http://ift.tt/1PD2KfQ —
5. Current Pharmaceutical Design 2013 — http://ift.tt/1mq85xO —
6. “Epidemiological and Biological Mechanisms of Cannabis as a Cause of Psychosis” 2012 – http://ift.tt/1ZG8fzc — page 113
7. PLoS One 2013 – http://ift.tt/1PD2LAq – Just found this! Delta-9-THC induces dopamine release in vulnerable patients, but not in controls.

—Minipoint 2A.2— MMN Amps
1. Biological Psychiatry 2013 – http://ift.tt/1mq87Wr —
2. European Archives of Psychiatry and Clinical Neuroscience 2010 – http://ift.tt/1ZG8dqY —
3. Schizophrenia Research Journal 2007 – http://ift.tt/1R6o9BH
—Minipoint 2A.3—Brain structure
1. European Archives of Psychiatry and Clinical Neuroscience 2013 – http://ift.tt/Wu2c4W –
2. Current Pharmaceutical Design 2012 – http://ift.tt/1R6oc0k – Psychosis review
3. Brain Topography Journal 2013 – http://ift.tt/1PD2KfR –
4. Schizophrenia Bulletin 2011 – http://ift.tt/1R6oc0m

http://ift.tt/1IJEzNv
via Web Design by Creatives Inside